Rezidivierte oder refraktäre KeimzelltumorenWelche Rolle spielt die Hochdosischemotherapie mit autologer Stammzelltransplantation?Relapsed or refractory germ cell tumorsWhat role does high-dose chemotherapy with autologous stem cell transplantation play?

被引:0
|
作者
L.A. Berger
K. Oechsle
机构
[1] Universitätsklinikum Hamburg Eppendorf,Hämatologie/Onkologie
来源
Der Onkologe | 2012年 / 18卷 / 11期
关键词
D O I
10.1007/s00761-012-2311-1
中图分类号
学科分类号
摘要
引用
收藏
页码:1031 / 1034
页数:3
相关论文
共 50 条
  • [21] Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell Cancers
    Sharma, Anand
    Babra, Deshveer S.
    Joshi, Priya, V
    Hall, Marcia
    Gogbashian, Andrew
    Vasdev, Nikhil
    Joseph, Magdalene
    Yazdan, Amir
    Kanfer, Edward
    IN VIVO, 2020, 34 (06): : 3675 - 3679
  • [22] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
    Alkhaldi, Hanan
    Reinhardt, Alec
    Barnett, Melissa
    Kundu, Suprateek
    Hosing, Chitra
    Ramdial, Jeremy
    Saini, Neeraj
    Srour, Samer
    Alousi, Amin
    Kebriaei, Partow
    Popat, Uday
    Qazilbash, Muzaffar
    Champlin, Richard
    Shpall, Elizabeth J.
    Gulbis, Allison
    Shigle, Terri Lynn
    Dabaja, Bouthaina
    Pinnix, Chelsea
    Ahmed, Sairah
    Steiner, Raphael
    Andersson, Borje S.
    Nieto, Yago
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 690 - 694
  • [23] High dose chemotherapy and autologous stem cell transplantation for salvage therapy of relapsed /refractory germ cell tumors; a single center experience
    Keskin, Gul Sema Yildiran
    Erturk, Ismail
    Aykan, Musa Baris
    Acar, Ramazan
    Dumludag, Aysegul
    Topal, Alper
    Koseoglu, Caglar
    Kuzu, Omer Faruk
    Ornek, Ece
    Karadurmus, Nuri
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (06) : 262 - 272
  • [24] Salvage high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with relapsed or refractory germ cell tumours: a Turkish oncology group study
    Arpaci, F.
    Ozturk, M.
    Ozdemir, E.
    Ozet, A.
    Ataergin, S.
    Dagdas, S.
    Kuzhan, O.
    Kilic, S.
    Ozturk, B.
    Komurcu, S.
    Ozet, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S155 - S156
  • [25] What is the optimal high-dose treatment following autologous stem cell transplantation in relapsed or refractory germ cell cancer: a retrospective comparison of high-dose ICE and high-dose CE
    Yildiz, Birol
    Aral, Ipek Pinar
    Balyemez, Ugurcan
    Esin, Ece
    Erturk, Ismail
    Acar, Ramazan
    Karadurmus, Nuri
    JOURNAL OF BUON, 2020, 25 (02): : 1136 - 1140
  • [26] Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphomaaEuro
    Gerrie, A. S.
    Power, M. M.
    Shepherd, J. D.
    Savage, K. J.
    Sehn, L. H.
    Connors, J. M.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2218 - 2223
  • [27] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes
    Engelhardt, Brian G.
    Holland, Derek W.
    Brandt, Stephen J.
    Chinratanalab, Wichai
    Goodman, Stacey A.
    Greer, John P.
    Jagasia, Madan H.
    Kassim, Adetola A.
    Morgan, David S.
    Ruffner, Katherine L.
    Schuening, Friedrich G.
    Wolff, Steven
    Bitting, Rhonda
    Sulur, Paulgun
    Stein, Richard S.
    LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1728 - 1735
  • [28] Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors
    Nieto, Y.
    Tu, S. -M.
    Bassett, R.
    Jones, R. B.
    Gulbis, A. M.
    Tannir, N.
    Kingham, A.
    Ledesma, C.
    Margolin, K.
    Holmberg, L.
    Champlin, R.
    Pagliaro, L.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2125 - 2132
  • [29] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    Aoki, T.
    Shimada, K.
    Suzuki, R.
    Izutsu, K.
    Tomita, A.
    Maeda, Y.
    Takizawa, J.
    Mitani, K.
    Igarashi, T.
    Sakai, K.
    Miyazaki, K.
    Mihara, K.
    Ohmachi, K.
    Nakamura, N.
    Takasaki, H.
    Kiyoi, H.
    Nakamura, S.
    Kinoshita, T.
    Ogura, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e372 - e372
  • [30] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    T Aoki
    K Shimada
    R Suzuki
    K Izutsu
    A Tomita
    Y Maeda
    J Takizawa
    K Mitani
    T Igarashi
    K Sakai
    K Miyazaki
    K Mihara
    K Ohmachi
    N Nakamura
    H Takasaki
    H Kiyoi
    S Nakamura
    T Kinoshita
    M Ogura
    Blood Cancer Journal, 2015, 5 : e372 - e372